The CARES Approach: Improving Glycemic, Cardiovascular, and Renal Outcomes

Released On
December 3, 2020

Expires On
December 3, 2021

Media Type

Completion Time
120 minutes

Endocrinology, Primary Care


Scroll to the Bottom of this Information to Begin this Course

Jointly provided by Med Learning Group and Ultimate Medical Academy/Complete Conference Management.


This activity is supported by educational grants from Lilly, Boehringer Ingelheim Pharmaceuticals, and Merck & Co., Inc.

Credit Available

  • Physicians — maximum of 2.00 AMA PRA Category 1 Credit(s)
  • Nurses — 2.00 contact hour(s).

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This educational activity is intended for cardiologists, endocrinologists, primary care physicians, NPs, PAs, nurses, and other clinicians involved in the treatment of patients with type 2 diabetes mellitus (T2DM).

Program Overview

This case-based enduring simulcast will cover the treatment and management of patients with type 2 diabetes mellitus.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Personalize the selection of therapies for the management of cardiovascular and renal risk in patients with T2DM based on up-to-date standards of care
  • Determine the clinical implications of results from cardiovascular outcomes trials of SGLT2 inhibitors and GLP-1 receptor agonists
  • Utilize guidelines-based strategies for treatment intensification in patients with T2DM not meeting their glycemic goals




Silvio E. Inzucchi, MD

Director, Yale Medicine Diabetes Center
Professor of Medicine, Endocrinology
Yale University School of Medicine
New Haven, CT

Anne L. Peters, MD

Professor of Medicine
Keck School of Medicine
University of Southern California
Westside Center for Diabetes
Los Angeles, CA

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Med Learning Group designates this enduring activity for a maximum of 2.00 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Continuing Education

Purpose: This program would be beneficial for nurses involved in the care of patients with type 2 diabetes mellitus.

Credits: 2.00 ANCC Contact Hour(s)

CNE Accreditation Statement

Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APNs.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosures of of Financial Relationships

Silvio E. Inzucchi, MD

  • Consultant: Boehringer Ingelheim, AstraZeneca, Sanofi/Lexicon, Novo Nordisk, Merck, vTv Therapeutics, Zafgen, Abbott/Alere, Eisai (TIMI)
  • Royalties: McGraw-Hill, Uptodate
  • Salary: Elsevier

Anne L. Peters, MD

  • Speakers’ Bureau: Novo Nordisk
  • Consultant: Abbott Diabetes Care, Becton Dickinson, Boehringer Ingelheim, Eli Lilly & Company, Lexicon, Livongo, MannKind, Medscape, Merck, Novo Nordisk, Omada Health, OptumHealth, Sanofi, Zafgen
  • Research Support: AstraZeneca, Dexcom, and MannKind
  • Donated Devices: Abbott Diabetes Care

The independent reviewers, staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:

CME Content Review

  • The content of this activity was independently peer reviewed.
  • The reviewer of this activity has nothing to disclose.

CNE Content Review

  • The content of this activity was peer reviewed by a nurse reviewer.
  • The reviewer of this activity has nothing to disclose.

Staff, Planners and Managers

  • Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
  • Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
  • Russie Allen, Outcomes Coordinator for Med Learning Group has nothing to disclose.
  • Marcello A. Morgan, MD, MPH, Medical Director, Scientific and Medical Services for Med Learning Group has nothing to disclose.
  • Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Method of Participation Participation

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate for download immediately, you will also get an email reminder.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the event at

For CME questions, please contact Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at"

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.